
Janis Marie Taube MD
Dermatopathology
Associate Professor of Dermatology, Associate Professor of Pathology, Johns Hopkins University School of Medicine
Join to view full profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Taube is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Dermatopathology, 2008 - 2009
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2008 - 2008
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2004 - 2007
Tulane University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2007 - Present
MD State Medical License 2009 - 2027
American Board of Pathology Pathology - Anatomic
American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.John V Heymach, Jie He, David Harpole, Tetsuya Mitsudomi, Janis M Taube
Journal of Clinical Oncology. 2026-08-28 - 1 citationsBiomarkers of nivolumab benefit in resectable non-small cell lung cancer.Tina Cascone, Mark M Awad, Jonathan D Spicer, Jie He, Shun Lu
Nature. 2026-08-12 - Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.Michael Lim, Xiaobu Ye, Anna F Piotrowski, Arati Desai, Manmeet S Ahluwalia
Nature Medicine. 2026-07-01
Journal Articles
- Pathological Assessment of Resection Specimens After Neoadjuvant Therapy for Metastatic MelanomaM T Tetzlaff, J E Gershenwald, X Xu, V G Prieto, T Mitchell, M A Davies, J M Taube, Annals of Oncology
Press Mentions
Interrogating the Complexities of the Tumor MicroenvironmentMay 19th, 2023
Researchers ID Biomarkers of Response to Immunotherapy for Kidney CancerApril 6th, 2023
Combinatorial Biomarker Predicts Response to Immunotherapy in Renal Cancer PatientsApril 6th, 2023
Grant Support
- Analytic and Clinical Validation of a 7-plex MIF Assay for Predictive Response of Advanced NSCLC to Anti-PD-1 based TherapyJOHNS HOPKINS UNIVERSITY2022–2029
- PD-1/PD-L1 modulation in cancer therapyJOHNS HOPKINS UNIVERSITY2010–2026
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/janis-taube
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: